Follow
Hajnalka Andrikovics
Hajnalka Andrikovics
Central Hospital of Southern Pest
Verified email at dpckorhaz.hu
Title
Cited by
Cited by
Year
Distinct clinical characteristics of myeloproliferative neoplasms with calreticulin mutations
H Andrikovics, T Krahling, K Balassa, G Halm, A Bors, M Koszarska, ...
haematologica 99 (7), 1184, 2014
1442014
Molecular diagnostics of myeloproliferative neoplasms
SE Langabeer, H Andrikovics, J Asp, B Bellosillo, S Carillo, K Haslam, ...
European journal of haematology 95 (4), 270-279, 2015
1042015
Analysis of large structural changes of the factor VIII gene, involving intron 1 and 22, in severe hemophilia A
H Andrikovics, I Klein, A Bors, L Nemes, A Marosi, A Váradi, A Tordai
haematologica 88 (7), 778-784, 2003
992003
A certified plasmid reference material for the standardisation of BCR–ABL1 mRNA quantification by real-time quantitative PCR
H White, L Deprez, P Corbisier, V Hall, F Lin, S Mazoua, S Trapmann, ...
Leukemia 29 (2), 369-376, 2015
962015
Isoform-specific up-regulation of plasma membrane Ca2+ ATPase expression during colon and gastric cancer cell differentiation
P Ribiczey, A Tordai, H Andrikovics, AG Filoteo, JT Penniston, J Enouf, ...
Cell calcium 42 (6), 590-605, 2007
832007
ATG16L1 and IL23 receptor (IL23R) genes are associated with disease susceptibility in Hungarian CD patients
PL Lakatos, T Szamosi, A Szilvasi, E Molnar, L Lakatos, A Kovacs, ...
Digestive and liver disease 40 (11), 867, 2008
762008
Decreased frequencies of ABCA1 polymorphisms R219K and V771M in Hungarian patients with cerebrovascular and cardiovascular diseases
H Andrikovics, E Pongrácz, Đ Kalina, A Szilvási, C Aslanidis, G Schmitz, ...
Cerebrovascular Diseases 21 (4), 254-259, 2006
732006
Association of some rare haplotypes and genotype combinations in the< i> MDR1</i> gene with childhood acute lymphoblastic leukaemia
ÁF Semsei, DJ Erdélyi, I Ungvári, E Kámory, B Csókay, H Andrikovics, ...
Leukemia research 32 (8), 1214-1220, 2008
682008
The R1141X loss-of-function mutation of the ABCC6 gene is a strong genetic risk factor for coronary artery disease
G Köblös, H Andrikovics, Z Prohászka, A Tordai, A Váradi, T Arányi
Genetic Testing and Molecular Biomarkers 14 (1), 75-78, 2010
672010
Synergistic interaction of ABCB1 and ABCG2 polymorphisms predicts the prevalence of toxic encephalopathy during anticancer chemotherapy
DJ Erdιlyi, E Kamory, B Csokay, H Andrikovics, A Tordai, C Kiss, ...
The pharmacogenomics journal 8 (5), 321-327, 2008
652008
Development and evaluation of a secondary reference panel for BCR-ABL1 quantification on the International Scale
NCP Cross, HE White, T Ernst, L Welden, C Dietz, G Saglio, FX Mahon, ...
Leukemia 30 (9), 1844-1852, 2016
582016
The role of the human ABCG2 multidrug transporter and its variants in cancer therapy and toxicology
J Cervenak, H Andrikovics, C Özvegy-Laczka, A Tordai, K Német, ...
Cancer letters 234 (1), 62-72, 2006
572006
High incidence of hemochromatosis gene mutations in the myelodysplastic syndrome: the Budapest Study on 50 patients
J Várkonyi, G Tarkovács, I Karádi, H Andrikovics, F Varga, J Demeter, ...
Acta haematologica 109 (2), 64-67, 2003
562003
Expression levels of the ABCG2 multidrug transporter in human erythrocytes correspond to pharmacologically relevant genetic variations
I Kasza, G Várady, H Andrikovics, M Koszarska, A Tordai, GL Scheffer, ...
PLoS One 7 (11), e48423, 2012
502012
ATP-binding cassette transporter ABCG2 (BCRP) and ABCB1 (MDR1) variants are not associated with disease susceptibility, disease phenotype response to medical therapy or need …
S Fischer, PL Lakatos, Hungarian IBD Study Group, L Lakatos, A Kovacs, ...
Scandinavian journal of gastroenterology 42 (6), 726-733, 2007
502007
Type and location of isocitrate dehydrogenase mutations influence clinical characteristics and disease outcome of acute myeloid leukemia
M Koszarska, A Bors, A Feczko, N Meggyesi, A Batai, J Csomor, E Adam, ...
Leukemia & lymphoma 54 (5), 1028-1035, 2013
472013
Additional chromosome abnormalities, BCR-ABL tyrosine kinase domain mutations and clinical outcome in hungarian tyrosine kinase inhibitor-resistant chronic myelogenous leukemia …
N Meggyesi, A Kozma, G Halm, S Nahajevszky, Á Bátai, S Fekete, A Barta, ...
Acta Haematologica 127 (1), 34-42, 2012
422012
First and second line imatinib treatment in chronic myelogenous leukemia patients expressing rare e1a2 or e19a2 BCR–ABL transcripts
H Andrikovics, S Nahajevszky, A Szilvási, A Bors, E Adám, A Kozma, ...
Hematological oncology 25 (3), 143-147, 2007
392007
The role of ABC-transporter gene polymorphisms in chemotherapy induced immunosuppression, a retrospective study in childhood acute lymphoblastic leukaemia
DJ Erdélyi, E Kámory, A Zalka, ÁF Semsei, B Csókay, H Andrikovics, ...
Cellular immunology 244 (2), 121-124, 2006
392006
JAK2 46/1 haplotype analysis in myeloproliferative neoplasms and acute myeloid leukemia
H Andrikovics, S Nahajevszky, M Koszarska, N Meggyesi, A Bors, G Halm, ...
Leukemia 24 (10), 1809-1813, 2010
372010
The system can't perform the operation now. Try again later.
Articles 1–20